![]()
|
|
||||||||
J. Biol. Chem., Vol. 266, Issue 6, 3661-3667, 02, 1991
T Ohashi, CM Hong, S Weiler, JM Tomich, JM Aerts, JM Tager and JA Barranger
Human cDNA was mutagenized to duplicate six naturally occurring mutations
in the gene for glucocere-brosidase. The mutant genes were expressed in NIH
3T3 cells. The abnormal human enzymes were purified by immunoaffinity
chromatography and characterized. The Asn370----Ser mutant protein differed
from normal enzyme in its inhibition by both conduritol B epoxide and
glucosphingosine demonstrating that the 370 mutant enzyme has an abnormal
catalytic site. In addition, the 370 mutant enzyme is less activated by
saposin C, but more stimulated by phosphatidylserine than the wild type
enzyme. The Arg463----Cys mutant protein was normal with respect to
conduritol B epoxide and glucosphingosine inhibition, but was less
activated by both saposin C and phosphatidylserine. The Arg120----Gln
mutant protein was catalytically inactive. The Leu444----Pro, the
pseudopattern, and the Pro415----Arg mutants appear to have reduced amounts
of enzyme protein in cells. The studies demonstrated that mutations in the
gene for glucocerebrosidase have different effects on the catalytic
activity and stability of the enzyme.
Characterization of human glucocerebrosidase from different mutant alleles
University of Southern California, Los Angeles 90024.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
E Beutler Gaucher disease: new molecular approaches to diagnosis and treatment Science, May 8, 1992; 256(5058): 794 - 799. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |